Previous 10 | Next 10 |
home / stock / stz / stz articles
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc. (NYSE: VSH) is "way too cheap." He ...
VICTOR, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE:STZ), a leading beverage alcohol company, announced today that ...
Constellation Brands (NYSE:STZ) has outperformed the market over the past 10 years by 3.34% on an annualized basis producing an average annual retu...
Constellation Brands (NYSE:STZ) has outperformed the market over the past 15 years by 11.05% on an annualized basis producing an average annual ret...
Beer Business Medium-Term ~7-9% Net Sales Growth and ~39-40% Operating Margins Outlook Unchanged Wine & Spirits Business Now Expects Medium-Te...
Anheuser-Busch Inbev SA (NYSE: BUD) inked a new multiyear marketing partnership with UFC, a mixed martial arts organization and part of T...
Constellation Brands (NYSE:STZ) has outperformed the market over the past 15 years by 10.24% on an annualized basis producing an average annual ret...
Beverage giant Coca-Cola (NYSE: KO) is one of several beverage and food stocks that have been hit due to potential concerns from weight loss drugs ...
On Thursday, Constellation Brands Inc (NYSE: STZ) touted the strong performance of its beer portfolio as the Corona beer maker raised its annu...
News, Short Squeeze, Breakout and More Instantly...
Constellation Brands Inc. Company Name:
STZ Stock Symbol:
NYSE Market:
Constellation Brands Inc. Website:
2024-07-09 07:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-05 08:15:04 ET UBS analyst issues BUY recommendation for STZ on July 5, 2024 07:02AM ET. The previous analyst recommendation was Buy. STZ was trading at $249.21 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recom...